FreeStyle Libre has been clinically shown to help reduce HbA1c in people living with T1D and Insulin-requiring T2D12,27,28
Type 1 diabetes
After 12-16 weeks
†In adults with T1D using FreeStyle Libre (p<0.0001 vs. baseline)12
Type 2 diabetes
After 10 weeks
*In people with T2D on multiple daily injections of insulin and FreeStyle Libre (p=0.005 vs. standard blood glucose monitoring)28
After 22 weeks
**In people with T2D who were using basal insulin and FreeStyle Libre (p<0.001 vs. baseline A1c)27
Lowering HbA1c reduces your risk of diabetes related complications
FreeStyle Libre has been shown to help reduce hypos in insulin-using people with both T1D and T2D6,17
Type 1 diabetes
After 6 months
less time spent in hypo in people with T1D
(p=0.0001 vs. standard blood glucose monitoring)6
A 6-month RCT in 328 well-controlled T1D patients (with baseline A1c ≤7.5%) proves the FreeStyle Libre system safely and successfully replaces SMBG.6
Type 2 diabetes
After 6 months
less time spent in hypo in people with T2D
(p=0.0006 vs. standard blood glucose monitoring)17
A 6-month RCT in 224 T2D patients on intensive insulin therapy proves the FreeStyle Libre system safely and successfully replaces SMBG.17
A reduction in hypoglycemic episodes could help you enjoy a better quality of life13 and reduce diabetes-related hospital admissions.10
Abbreviations: A1c: glycated haemoglobin; hypo: hypoglycemic event; RCT: randomised controlled trial; SMBG: self-monitoring of blood glucose; T1D: type 1 diabetes; T2D: type 2 diabetes.
References: 6. Bolinder J, et al. Lancet. 2016;388(10057):2254-2263. 10. Charleer S, et al. Diabetes Care 2020;43(2):389-397. 12. Evans M, et al. Diabetes Ther 2022. https://doi.org/10.1007/s13300-022-01253-9. 13. Fokkert M, et al. BMJ Open Diab Res Care 2019;7(1):e000809. 17. Haak T, et al. Diabetes Therapy 2017;8:55-73. 27. Wright E, et al. Diabetes Spectrum. 2021;34(2):184–189. 28. Yaron, M. Diabetes Care 2019;42(7):1178–1184.
Stay connected